Cardio Diagnostics Holdings, Inc.(CDIO)

Biotechnology · Chicago, IL

$2.06+0.10 (+5.10%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Cardio Diagnostics Holdings (CDIO) Price/FCF Ratio: History & Chart | TGMCharts

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T12:50:56.293Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:56.293Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 6,096,506
TTM free cash flow · period ending 2026-06-30: -5,841,460

FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CDIO Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

CDIO Competitors' Price/FCF Ratio

CDIO

Cardio Diagnostics Holdings, Inc.

Current

Market Cap

$6.10M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FEMY

Femasys Inc.

vs CDIO

Market Cap

$6.10M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENLV

Enlivex Therapeutics Ltd.

vs CDIO

Market Cap

$6.09M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs CDIO

Market Cap

$6.03M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMRA

Biomerica, Inc.

vs CDIO

Market Cap

$6.34M

Price/FCF Ratio

N/A

TTM Avg

129.84

3Y Avg

129.84

5Y Avg

129.84

ENSC

Ensysce Biosciences, Inc.

vs CDIO

Market Cap

$6.44M

Price/FCF Ratio

N/A

TTM Avg

1251.36

3Y Avg

3596.79

5Y Avg

3596.79

ACXP

Acurx Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.63M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs CDIO

Market Cap

$5.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLT

Bolt Biotherapeutics, Inc.

vs CDIO

Market Cap

$6.72M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACON

Aclarion, Inc.

vs CDIO

Market Cap

$6.74M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Cardio Diagnostics Holdings, Inc. (CDIO)	$6.10M	N/A	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.10M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$6.09M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$6.03M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.34M	N/A	129.84	129.84	129.84
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.44M	N/A	1251.36	3596.79	3596.79
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.54M	N/A	N/A	N/A	N/A
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.72M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.74M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

CDIO Price/FCF Ratio Metrics

CDIO Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics